Gainers
- TuHURA Biosciences HURA stock increased by 17.4% to $2.46 during Wednesday's after-market session. The market value of their outstanding shares is at $104.0 million.
- SenesTech SNES stock moved upwards by 16.23% to $2.65. The market value of their outstanding shares is at $2.7 million. As per the press release, Q4 earnings came out today.
- BioSig Technologies BSGM stock increased by 12.64% to $0.8. The market value of their outstanding shares is at $18.4 million.
- Scienture Holdings SCNX shares moved upwards by 12.41% to $1.46. The company's market cap stands at $12.5 million.
- cbdMD YCBD shares rose 8.99% to $0.29. The company's market cap stands at $1.8 million.
- Seres Therapeutics MCRB stock rose 8.19% to $0.75. The company's market cap stands at $128.0 million.
Losers
- Cutera CUTR stock decreased by 52.5% to $0.05 during Wednesday's after-market session.
- Aditxt ADTX shares declined by 39.27% to $0.03. The company's market cap stands at $2.7 million.
- Hepion Pharmaceuticals HEPA stock decreased by 18.86% to $0.04.
- Syros Pharmaceuticals SYRS shares fell 9.98% to $0.08. The company's market cap stands at $2.0 million.
- Biote BTMD stock declined by 9.76% to $3.7. The company's market cap stands at $115.1 million. As per the press release, Q4 earnings came out today.
- China Pharma Holding CPHI stock decreased by 7.03% to $0.25. The company's market cap stands at $4.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADTXAditxt Inc
$1.03-%
Edge Rankings
Momentum
0.28
Growth
N/A
Quality
N/A
Value
3.62
Price Trend
Short
Medium
Long
BSGMBioSig Technologies Inc
$5.234.81%
BTMDBiote Corp
$3.226.62%
CPHIChina Pharma Holding Inc
$1.43-3.38%
HEPAHepion Pharmaceuticals Inc
$0.0500-84.3%
HURATuHURA Biosciences Inc
$3.2210.7%
MCRBSeres Therapeutics Inc
$17.38-5.14%
SCNXScienture Holdings Inc
$1.052.92%
SNESSenesTech Inc
$4.47-0.67%
SYRSSyros Pharmaceuticals Inc
$0.0199-83.0%
YCBDcbdMD Inc
$0.70008.70%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.